We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

274 hedge funds and large institutions have $3.85B invested in Intra-Cellular Therapies Inc. in 2022 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 103 increasing their positions, 86 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 35

20% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 86

13% more call options, than puts

Call options by funds: $21.3M | Put options by funds: $18.9M

3% more funds holding

Funds holding: 266 → 274 (+8)

16% less capital invested

Capital invested by funds: $4.57B → $3.85B (-$727M)

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

Holders
274
Holders Change
+8
Holders Change %
+3.01%
% of All Funds
4.72%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.12%
New
43
Increased
103
Reduced
86
Closed
35
Calls
$21.3M
Puts
$18.9M
Net Calls
+$2.43M
Net Calls Change
-$6.17M

Top Buyers

1
GKIM
GW&K Investment Management
Massachusetts
+$46.1M
2
Invesco
Invesco
Georgia
+$45.3M
3
Millennium Management
Millennium Management
New York
+$42M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$36.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$34.3M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$43.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$36.5M
3
DCM
Driehaus Capital Management
Illinois
-$29.4M
4
SCM
Suvretta Capital Management
New York
-$25.4M
5
CAM
Cormorant Asset Management
Massachusetts
-$15.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
QPW
151
Quantum Private Wealth
Florida
$772K -$2.63M -50,325 -75%
E
152
Ergoteles
New York
$732K +$636K +12,175 +341%
HSA
153
Hussman Strategic Advisors
Maryland
$721K +$810K +15,500 New
Teacher Retirement System of Texas
154
Teacher Retirement System of Texas
Texas
$720K +$125K +2,391 +18%
AB
155
Amalgamated Bank
New York
$690K +$8.41K +161 +1%
FSA
156
Franklin Street Advisors
North Carolina
$652K -$131K -2,500 -15%
PP
157
PDT Partners
New York
$628K +$705K +13,493 New
AP
158
AtonRa Partners
Switzerland
$561K -$8.25K -158 -1%
Handelsbanken Fonder
159
Handelsbanken Fonder
Sweden
$549K – – –
KOCAA
160
Knights of Columbus Asset Advisors
Connecticut
$535K +$71.4K +1,367 +14%
Simplex Trading
161
Simplex Trading
Illinois
$531K +$597K +11,431 New
Zurich Cantonal Bank
162
Zurich Cantonal Bank
Switzerland
$520K – – –
Connor, Clark & Lunn Investment Management (CC&L)
163
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$513K +$40.3K +772 +8%
CAM
164
Connacht Asset Management
New York
$507K +$570K +10,906 New
Citigroup
165
Citigroup
New York
$499K -$324K -6,209 -37%
CF
166
CNA Financial
Illinois
$489K -$6.27K -120 -1%
GAM
167
Gemmer Asset Management
California
$489K – – –
Public Employees Retirement Association of Colorado
168
Public Employees Retirement Association of Colorado
Colorado
$482K – – –
HF
169
HRT Financial
New York
$478K +$537K +10,279 New
IMRF
170
Illinois Municipal Retirement Fund
Illinois
$470K – – –
FAIM
171
Financial Advocates Investment Management
Washington
$466K +$146K +2,788 New
JF
172
Jump Financial
Illinois
$465K +$522K +10,000 New
JMPWA
173
JP Morgan Private Wealth Advisors
California
$460K +$287K +5,485 +125%
VRS
174
Virginia Retirement Systems
Virginia
$442K +$496K +9,500 New
GC
175
Guggenheim Capital
Illinois
$435K +$33.3K +638 +7%
5 6
7
8 9

ITCI Hedge Fund Activity: Q3 2022 in Review

274 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q3 2022, worth a combined $3.85B — down 16% from $4.57B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new ITCI positions and 35 closed out — a net gain of 8 holders — while 103 added to existing stakes and 86 trimmed.

The largest buyer was GW&K Investment Management, adding an estimated $46.1M. The largest seller was Victory Capital Management, cutting an estimated $43.9M.

  • 274 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q3 2022, up from 266 in Q2 2022.
  • Funds reported $3.85B of Intra-Cellular Therapies Inc. stock for Q3 2022, down 16% quarter-over-quarter.
  • 43 funds opened new Intra-Cellular Therapies Inc. positions in Q3 2022 and 35 closed out, a net change of +8 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q3 2022 was GW&K Investment Management, an estimated $46.1M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q3 2022 was Victory Capital Management, an estimated $43.9M sold.

Based on aggregated 13F filings for Q3 2022.